A multi-centre research team from the UK and the USA has discovered the first method to deliver medication directly into the encysted stage of the infectious parasites that cause toxoplasmosis and a novel target for medicines in the parasite. It has major implications for the way that we treat this devastating disease as it could lead to new medications and approaches to better tackle it. The study will be published online on November 17 by the Proceedings of the National Academy of Sciences (PNAS).
Toxoplasmosis is a parasitic infection from the apicomplexan family, which includes the causes of malaria and cryptosporidiosis. The disease is caused by a single celled organism called Toxoplasma gondii and is spread by cats and by eating undercooked meat. Toxoplasmosis is a common disease and can cause devastating problems for those with weakened immune systems, or when transmitted from mother to unborn child. It can lead to blindness, retardation and even death.
Professor David Rice, from the Department of Microbiology and Biotechnology at the University of Sheffield, was involved in the study. He explains, "Toxoplasma infections are especially difficult to treat because they recur. The disease operates in two stages, a proliferative stage and a latent stage. During the proliferative stage the infection can be treated, although there are many problems with available medicines, but the illness then progresses to a latent stage, where the cysts form that hold the parasites in a less active state. These cysts are untreatable as scientists cant get medication inside the cyst. The cysts eventually rupture and release proliferating parasites, which can cause a recurrence of the illness if the immune system is weakened and in those with eye disease. Such recurrences can cause severe damage to the eye and nervous system."
Lorna Branton | alfa
'Exciting' discovery on path to develop new type of vaccine to treat global viruses
18.09.2017 | University of Southampton
A new approach to high insulin levels
18.09.2017 | Schweizerischer Nationalfonds SNF
Using ultrafast flashes of laser and x-ray radiation, scientists at the Max Planck Institute of Quantum Optics (Garching, Germany) took snapshots of the briefest electron motion inside a solid material to date. The electron motion lasted only 750 billionths of the billionth of a second before it fainted, setting a new record of human capability to capture ultrafast processes inside solids!
When x-rays shine onto solid materials or large molecules, an electron is pushed away from its original place near the nucleus of the atom, leaving a hole...
For the first time, physicists have successfully imaged spiral magnetic ordering in a multiferroic material. These materials are considered highly promising candidates for future data storage media. The researchers were able to prove their findings using unique quantum sensors that were developed at Basel University and that can analyze electromagnetic fields on the nanometer scale. The results – obtained by scientists from the University of Basel’s Department of Physics, the Swiss Nanoscience Institute, the University of Montpellier and several laboratories from University Paris-Saclay – were recently published in the journal Nature.
Multiferroics are materials that simultaneously react to electric and magnetic fields. These two properties are rarely found together, and their combined...
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems Holding GmbH about commercial use of a multi-well tissue plate for automated and reliable tissue engineering & drug testing.
MBM ScienceBridge GmbH successfully negotiated a license agreement between University Medical Center Göttingen (UMG) and the biotech company Tissue Systems...
Pathogenic bacteria are becoming resistant to common antibiotics to an ever increasing degree. One of the most difficult germs is Pseudomonas aeruginosa, a...
Scientists from the MPI for Chemical Energy Conversion report in the first issue of the new journal JOULE.
Cell Press has just released the first issue of Joule, a new journal dedicated to sustainable energy research. In this issue James Birrell, Olaf Rüdiger,...
19.09.2017 | Event News
12.09.2017 | Event News
06.09.2017 | Event News
19.09.2017 | Event News
19.09.2017 | Physics and Astronomy
19.09.2017 | Power and Electrical Engineering